findmyKOL

Pushpa Narayanaswami, MD

Enriched profile

Professor of Clinical Neurology, Harvard Medical School; Vice Chair of Clinical Operations, Department of Neurology, Beth Israel Deaconess Medical Center · Beth Israel Deaconess Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyNeurologyFocusMyasthenia Gravis and Thymoma+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH funding2007–2025

Pushpa Narayanaswami is Professor of Clinical Neurology, Harvard Medical School; Vice Chair of Clinical Operations, Department of Neurology, Beth Israel Deaconess Medical Center at Beth Israel Deaconess Medical Center. OpenAlex indexes 161 publications with 5,331 citations (h-index 30); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 12 Oct 2026

Overview

Updated 14 Oct 2026

Pushpa Narayanaswami, MD, is Professor of Clinical Neurology, Harvard Medical School at Beth Israel Deaconess Medical Center / Harvard Medical School. The public record shows 161 publications with 5,331 citations (h-index 30), centered on Myasthenia Gravis and Thymoma, Peripheral Neuropathies and Disorders, Ophthalmology and Eye Disorders. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 12 companies, 2 NIH-funded awards (2007–2025).

  • Most recent indexed publication: 2026 · Muscle & nerve
  • Top research focus: Myasthenia Gravis and Thymoma
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 12 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Sialorrhea1 trialAutoimmune Diseases1 trialImmune System Diseases1 trialMyasthenia Gravis1 trialAsthenia1 trialMuscular Dystrophies1 trialMuscular Diseases1 trialMyositis1 trialDistal Myopathies1 trialMyofibrillar Myopathy1 trialParkinson's Disease1 trialALS1 trialMotor Neuron Disease1 trial

Research focus

OpenAlex concept fingerprint
Myasthenia Gravis and ThymomaPeripheral Neuropathies and DisordersOphthalmology and Eye DisordersNeurogenetic and Muscular Disorders ResearchInflammatory Myopathies and Dermatomyositis

Drugs & molecules

across trials, industry payments and publications
Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments9Publications1Solirisgeneric · EculizumabClinical trials—Industry payments25Publications—Ultomirisgeneric · RavulizumabClinical trials—Industry payments17Publications—Upliznageneric · InebilizumabClinical trials—Industry payments13Publications—Rystiggogeneric · RozanolixizumabClinical trials—Industry payments9Publications—Vyvgart Hytrulogeneric · Efgartigimod alfa / hyaluronidaseClinical trials—Industry payments5Publications—Zilbrysqgeneric · ZilucoplanClinical trials—Industry payments4Publications—

Works with

trial sponsors and companies reporting payments
Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments53Ucb SaClinical trials—Industry payments40Janssen Global Services, LLCClinical trials—Industry payments35UCB, Inc.Clinical trials—Industry payments30Argenx Us, Inc.Clinical trials—Industry payments17Amgen Inc.Clinical trials—Industry payments12Janssen Scientific Affairs, LLCClinical trials—Industry payments4Beth Israel Deaconess Medical CenterClinical trials3Industry payments—Sanofi-Aventis U.S. LLCClinical trials—Industry payments3Biogen, Inc.Clinical trials—Industry payments1Cabaletta BioClinical trials1Industry payments—Duke UniversityClinical trials1Industry payments—Horizon Therapeutics plcClinical trials—Industry payments1Merck KGaAClinical trials—Industry payments1Sarepta Therapeutics, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
161publications

Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.

5,331citations

Total citations across indexed works.

30h-index

Hirsch index (OpenAlex). i10-index 54.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
12companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2007–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    73.3%
    Gabapentinoids24.6%
    Gabapentin100%
    Part D≥17 patients
    Anti-epileptic Agent8.5%
    Oxcarbazepine40%Primidone30%Zonisamide30%
    Part D<11 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    22.2%
    Corticosteroid18.8%
    Prednisone100%
    Part D≥13 patients
    H2 blocker3.4%
    Famotidine100%
    Part D<11 patients
  • Cardiovascular

    2.4%
    Antiarrhythmic2.4%
    Lidocaine100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)70.8% facility · 29.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

2 NIH research awards on record, funded 2007–2025 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Gil I. Wolfe17Seward B. Rutkove17Donald B. Sanders16James F. Howard13Gary Gronseth12Tulio E. Bertorini11Jeffrey T. Guptill10Andreas Meisel9Aditi Ahlawat8Maike Stein8Michael Pulley8Lea Morrin Gerischer7Michael G Benatar7Sophie Mirabell Lehnerer7Srikanth Muppidi6Jeremy M. Shefner6Neelam Goyal6Nicholas J. Silvestri6Ted M. Burns6Samir Macwan6Christopher T. Bever6Tahseen Mozaffar6Michael W Nicolle5Meret Luise Herdick5Melissa J. Armstrong5Michael K. Hehir5Elizabeth M. Raynor5Nils Erik Gilhus5Charles D. Kassardjian5Ali Aamer Habib5Haoqi Sun5Allison Foss5Maximilian Mönch5Aimee K. Boegle4Jodie K. Haselkorn4Jürgen Venitz4Francesco Saccà4Mayvis Rebeira4Lyell K. Jones4James B. Caress4

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2024.myana.org ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American Academy of Neurology (FAAN)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2024.myana.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Leader

    Myasthenia Gravis Center of Excellence, Beth Israel Deaconess Medical Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.bidmc.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.